Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  temsirolimus
Find trials that include:  Any drugs shown
Results 1-14 of 14 for your search:
Start Over
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, 2009-015498-11, B1771007, NCT01180049
Pazopanib Hydrochloride or Temsirolimus in Treating Patients With Metastatic or Locally Advanced Kidney Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0358, NCI-2011-01277, NCT01392183
Alternating Sunitinib Malate and Temsirolimus Therapy in Treating Patients With Metastatic Kidney Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: D1011, NCI-2011-03505, NCT01517243
Temsirolimus and Sorafenib Tosylate in Treating Patients With Stage II-IV Liver Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 124511, NCI-2012-02021, NCT01687673
Irinotecan Hydrochloride and Temozolomide with Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Children
Trial IDs: ANBL1221, NCI-2012-03125, CDR0000745188, COG-ANBL1221, NCT01767194
Pegylated Liposomal Doxorubicin Hydrochloride, Bevacizumab, and Temsirolimus in Treating Patients With Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 and over
Trial IDs: 2008-0384, NCI-2012-01665, NCT00761644
Temsirolimus and Vorinostat in Treating Patients with Metastatic Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: I 150709, NCI-2009-01537, RPCI I 150709, NCT01174199
Bevacizumab, Temsirolimus with or without Carboplatin, Paclitaxel, or Sorafenib Tosylate in Treating Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2010-0486, NCI-2012-01788, NCI-2010-01947, NCT01187199
Temsirolimus and Metformin Hydrochloride in Treating Patients with Advanced or Metastatic Cancer
Phase: Phase I
Type: Treatment
Age: 14 and over
Trial IDs: 2011-0923, NCI-2012-00216, NCT01529593
Vemurafenib with Everolimus or Temsirolimus in Treating Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2012-0153, NCI-2012-00789, NCT01596140
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 21
Trial IDs: T2014-001, NCI-2012-01493, T2008-004, NCT01614197
Tivantinib and Temsirolimus in Treating Patients with Solid Tumors That is Metastatic or Cannot be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CO 11914, NCI-2012-00949, 905854-02-06, NCI-2012-00974, NCI 9145, 9145, NCT01625156
Start Over